| Active substance | Idebenone |
| Holder | Santhera Pharmaceuticals GmbH |
| Status | Closed |
| Indication | Leber’s hereditary optic neuropathy (LHON) |
| Public documents | Approbation |
| Information for the patient | |
| Informed consent | |
| Last update | 07/10/2019 |
Raxone®
Last updated on 13/09/2024